• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    Lifeward to Report First Quarter 2025 Financial Results on May 15, 2025

    5/7/25 4:30:25 PM ET
    $LFWD
    Industrial Specialties
    Health Care
    Get the next $LFWD alert in real time by email

    MARLBOROUGH, Mass. and YOKNEAM ILLIT, Israel, May 07, 2025 (GLOBE NEWSWIRE) -- Lifeward Ltd. (NASDAQ:LFWD) ("Lifeward" or the "Company"), a  global leader in innovative medical technology to transform the lives of people with physical limitations or disabilities, today announced that the Company will release its first quarter 2025 financial results before the markets open on Thursday, May 15, 2025.

    Larry Jasinski, Chief Executive Officer, and Mike Lawless, Chief Financial Officer, will host a conference call and live webcast at 8:30 a.m. EDT to discuss the financial results. To access the call, analysts and investors may utilize the following:

    Toll free (U.S.)1-833-316-0561
    International (U.S)1-412-317-0690
    Germany0800-6647650
    Israel1-80-9212373
    Access CodePlease reference the "Lifeward Earnings Call"
      

    The conference call will be webcast live and the webcast can be accessed through a link on the Company's website at GoLifeward.com in the "Investors" section, or through the following link: https://edge.media-server.com/mmc/p/5e35v6wk. An archived webcast will also be available on the company's website.

    About Lifeward

    Lifeward designs, develops, and commercializes life-changing solutions that span the continuum of care in physical rehabilitation and recovery, delivering proven functional and health benefits in clinical settings as well as in the home and community. Our mission at Lifeward is to relentlessly drive innovation to change the lives of individuals with physical limitations or disabilities. We are committed to delivering groundbreaking solutions that empower individuals to do what they love. The Lifeward portfolio features innovative products including the ReWalk Exoskeleton, the AlterG Anti-Gravity system, the MyoCycle FES System, and the ReStore Exo-Suit.

    Founded in 2001, Lifeward has operations in the United States, Israel, and Germany. For more information on the Lifeward mission and product portfolio, please visit GoLifeward.com.

    Lifeward®, ReWalk®, ReStore® and Alter G® are registered trademarks of Lifeward Ltd. and/or its affiliates.   

    Lifeward Media Relations:

    Kathleen O'Donnell

    Vice President, Marketing & New Business Development

    Lifeward Ltd.

    E: [email protected]

    Lifeward Investor Contact:

    Mike Lawless

    Chief Financial Officer

    Lifeward Ltd.

    E: [email protected]



    Primary Logo

    Get the next $LFWD alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $LFWD

    DatePrice TargetRatingAnalyst
    2/10/2025$10.00Buy
    Laidlaw
    More analyst ratings

    $LFWD
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • SEC Form 4 filed by President & Co-CEO Grant William Mark

      4 - Lifeward Ltd. (0001607962) (Issuer)

      6/4/25 5:54:35 PM ET
      $LFWD
      Industrial Specialties
      Health Care
    • SEC Form 3 filed by new insider Grant William Mark

      3 - Lifeward Ltd. (0001607962) (Issuer)

      6/4/25 5:54:01 PM ET
      $LFWD
      Industrial Specialties
      Health Care
    • Chief Executive Officer Jasinski Lawrence J sold $2,405 worth of Ordinary Shares (1,909 units at $1.26) (SEC Form 4)

      4 - Lifeward Ltd. (0001607962) (Issuer)

      5/22/25 4:29:09 PM ET
      $LFWD
      Industrial Specialties
      Health Care

    $LFWD
    SEC Filings

    See more
    • SEC Form S-1 filed by Lifeward Ltd.

      S-1 - Lifeward Ltd. (0001607962) (Filer)

      6/20/25 9:08:57 AM ET
      $LFWD
      Industrial Specialties
      Health Care
    • Lifeward Ltd. filed SEC Form 8-K: Leadership Update, Shareholder Director Nominations

      8-K - Lifeward Ltd. (0001607962) (Filer)

      6/16/25 9:26:58 AM ET
      $LFWD
      Industrial Specialties
      Health Care
    • SEC Form PRE 14A filed by Lifeward Ltd.

      PRE 14A - Lifeward Ltd. (0001607962) (Filer)

      6/16/25 9:15:57 AM ET
      $LFWD
      Industrial Specialties
      Health Care